These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33264518)

  • 41. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic model and nomogram construction based on autophagy signatures in lower grade glioma.
    Wang C; Qiu J; Chen S; Li Y; Hu H; Cai Y; Hou L
    J Cell Physiol; 2021 Jan; 236(1):235-248. PubMed ID: 32519365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BTK Expression Level Prediction and the High-Grade Glioma Prognosis Using Radiomic Machine Learning Models.
    Jiang C; Sun C; Wang X; Ma S; Jia W; Zhang D
    J Imaging Inform Med; 2024 Aug; 37(4):1359-1374. PubMed ID: 38381384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
    Shee K; Chambers M; Hughes EG; Almiron DA; Deharvengt SJ; Green D; Lefferts JA; Andrew AS; Hickey WF; Tsongalis GJ
    J Neurooncol; 2020 Jul; 148(3):473-480. PubMed ID: 32583303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
    Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
    JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
    Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
    Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
    Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN
    Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
    Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
    Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
    Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
    Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk assessment model constructed by differentially expressed lncRNAs for the prognosis of glioma.
    Hu C; Zhou Y; Liu C; Kang Y
    Oncol Rep; 2018 Nov; 40(5):2467-2476. PubMed ID: 30106138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of IGF2BP3 as an Adverse Prognostic Biomarker of Gliomas.
    Sun C; Zheng X; Sun Y; Yu J; Sheng M; Yan S; Zhu Q; Lan Q
    Front Genet; 2021; 12():743738. PubMed ID: 34721530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of hub genes related to prognosis in glioma.
    Zhang D; Zhao J; Han C; Liu X; Liu J; Yang H
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
    Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
    Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
    Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
    Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of m6A regulators and the nomogram construction in glioma patients.
    Liu P; Yan X; Ma C; Gu J; Tian F; Qu J
    Medicine (Baltimore); 2022 Sep; 101(37):e30643. PubMed ID: 36123877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
    Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
    J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.